Skip to main content
Premium Trial:

Request an Annual Quote

Tauriga Sciences Completes $600K Private Placement

NEW YORK (GenomeWeb) – Tauriga Sciences said on Thursday that it completed a $600,000 private placement with unnamed institutional and accredited individual investors.

The proceeds will be directed in part to advance the commercialization of the synthetic biology technology platform of its wholly owned subsidiary, Pilus Energy, for industrial wastewater remediation. The platform, called the Electrogenic Bioreaction system, harnesses genetically enhanced bacteria.

Tauriga, headquartered in Danbury, Conn., is a diversified company focused on the development of a nano-robotics technology platform. Proceeds will also go toward other working capital purposes, including growing the revenues of its natural wellness businesses, it said.

Tauriga also said that Tokyo-based Dragoon Capital has invested a total of $350,000 in the company, though it did not specify that Dragoon participated in the most recent financing.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.